π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2016-12
Trial ID
NCT02926053
This clinical trial aims to investigate the safety, optimal dosage, and eff...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-09-01
Trial ID
NCT06559644
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
The purpose of this first in human study is to evaluate the feasibility, sa...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2022-11-22
Trial ID
NCT05628883
Treatments Being Tested
98 participants will be randomly assigned 1:1 to the experimental group and...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-12-20
Trial ID
NCT06703398
Treatments Being Tested
This research study aims to evaluate the safety and effectiveness of a nove...
Status
Recruiting
Location
AHN West Penn Hospital
Start Date
2026-06-03
Trial ID
NCT07192900
Treatments Being Tested
This is a single-arm study aimed at evaluating the safety of TILs therapy f...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07498439
Treatments Being Tested
This study will investigate the safety and efficacy of TIL therapy in patie...
Status
Completed
Location
Yale School of Medicine
Start Date
2019-12-23
Trial ID
NCT04111510
Treatments Being Tested